Biological/Vaccine: therapeutic autologous dendritic cells.
CDR0000068493
Phase 1 mab terminated
Quick answer
Biological/Vaccine: therapeutic autologous dendritic cells. for Kidney Cancer is a Phase 1 program (mab) at LISATA THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LISATA THERAPEUTICS, INC.
- Indication
- Kidney Cancer
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated